Trials / Terminated
TerminatedNCT01755650
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
A Phase 0 Exploratory Microdosing Study of S-(3-18Ffluoropropyl)Homocysteine Hydrochloride; 18FFPM Using PET/CT in Patients With a Variety of Malignancies.
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Peter MacCallum Cancer Centre, Australia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and potential effectiveness of the imaging compound 18F FPM for finding sites of malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 18F FPM |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2017-11-03
- Completion
- 2017-11-03
- First posted
- 2012-12-24
- Last updated
- 2023-09-13
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01755650. Inclusion in this directory is not an endorsement.